Association between genetically proxied PPARG activation and early onset Alzheimer's disease: A drug target Mendelian randomization study
This study suggests that Thiazolidinedione therapy could help suppress the development of EOAD, supporting further exploration of PPARG-targeted anti-diabetic drug development.
Authors
- Qianqian Jin (ORCID: https://orcid.org/0000-0003-2502-7886)
- Yi‐Lin Wu (ORCID: https://orcid.org/0000-0002-2747-7015)
- Lingyu Zhang (ORCID: https://orcid.org/0000-0002-3121-2984)
- Chunfang Wang (ORCID: https://orcid.org/0009-0004-0772-4594)
Institutions
- Shanxi Medical University (CN)
Publication Details
- Journal
- Journal of Alzheimer s Disease Reports
- Published
- 2025-07-21
- DOI
- https://doi.org/10.1177/25424823251359579
- Citations
- 2
- Primary Topic
- Peroxisome Proliferator-Activated Receptors
- Type
- article
- Field-Weighted Citation Impact
- 1.61